MCED Consortium appoints leaders
January 27, 2022 -- The Multicancer Early Detection (MCED) Consortium has named Michelle Le Beau, PhD, as chair and Dr. Larry Kessler as deputy chair to lead the new organization's efforts evaluating the clinical and public health value of MCED tests. Read More
Sophia names Ken Freedman as chief revenue officer
January 27, 2022 -- Sophia Genetics has appointed Ken Freedman as chief revenue officer. Freedman brings more than 25 years of sales, marketing, and executive management experience, Sophia said. Read More
'Lab in a backpack' promises low-cost, accessible COVID testing
January 26, 2022 -- A new proof-of-concept study tested a $51 "lab in a backpack" that promises to bring accessible, low-cost COVID-19 testing to anywhere in the world, according to research published on January 26 in PLOS One. The researchers hope that their model can be used to develop commercial tests for less than $15. Read More
How to apply for the AACC's Disruptive Technology Award
January 25, 2022 -- The February 7 deadline to apply for the American Association for Clinical Chemistry's (AACC) Disruptive Technology Award is drawing close. The award can give a major boost to startup companies developing new diagnostics technologies. Read More
CAP accredits LSU's Precision Medicine Lab
January 25, 2022 -- The College of American Pathologists (CAP) recently accredited the Precision Medicine Laboratory at Louisiana State University (LSU) Health New Orleans School of Medicine. Read More
Veracyte touts results of Percepta genomic sequencing study
January 25, 2022 -- Veracyte has released data from a study that used the company's Percepta genomic sequencing classifier, which the company reported can deliver curative therapy for patients with high-risk lung nodules and inconclusive bronchoscopy results. Read More
Illumina to collaborate with Japan's National Cancer Center
January 24, 2022 -- Illumina and Japan's National Cancer Center have announced a collaboration that will use Illumina's DNA sequencing assay TruSight Oncology 500 ctDNA to analyze the blood-based profile of nasopharyngeal cancer. Read More
Eurofins subsidiary launches at-home test for 'forever chemicals'
January 24, 2022 -- Eurofins Scientific subsidiary EmpowerDX has launched a new at-home blood test to detect and measure more than 40 per- and polyfluorinated alkyl substances (PFAS), so-called "forever chemical" compounds. Read More
PathGroup acquires Pathology Consultants
January 24, 2022 -- PathGroup, a provider of anatomic pathology, digital pathology, and clinical and molecular laboratory services, announced that it acquired Pathology Consultants, a provider of pathology services that is based in Greenville, SC. Read More
New test detects DNA damage in sperm with greater accuracy
January 21, 2022 -- A new test can measure the amount of DNA damage in sperm with greater accuracy than current tests. The new method may improve the diagnosis of male infertility, according to research published on January 20 in the journal Clinical Chemistry. Read More